%L publicatio10113
%A  HollĂĄn Zsuzsa
%A  VĂŠcsei LĂĄszlĂł
%A  Magyar KĂĄlmĂĄn
%X A patient with triosephosphate isomerase (TPI) deficiency exhibited worsening of abnormal involuntary movements of the dystonic type and developed psychiatric symptoms while on selegiline. When selegiline was stopped after 9 years of treatment, abnormal involuntary movements improved to pretreatment level and psychiatric behaviour returned to normal. Monoamine oxidase-B platelet activity was low in this patient. (C) 2003 Movement Disorder Society.
%V 19
%R 1032213
%P 107-109
%O FELTÖLTŐ: Gyengéné Ruszka Marian - gyengeneruszka@freemail.hu
%D 2004
%N 1
%T Adverse effects of dopamine potentiation by long-term treatment with selegiline
%I szte
%J MOVEMENT DISORDERS